Resultados de la búsqueda 51-60 of 15272 for Huntington's+disease
Page 1.
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
... and, the discovery of new, potentially relevant biomarkers of risk in fresh and frozen specimens of benign breast disease. Study of Pembrolizumab (MK-3475) ...
... and HRQOL outcomes specific for patients with metastatic spine tumor(s). A ... and frozen specimens of benign breast disease. A Study to Analyze ...
Rochester, Minn., Jacksonville, Fla. The purpose of this study is to look at the effects cancer and melanoma have on the immune cells found in lymph nodes.
Rochester, Minn. The purpose of this study is to evaluate the new QFT-Plus assay compared to the QFT-Gold assay and the tuberculin skin test results ( ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
... and HRQOL outcomes specific for patients with metastatic spine tumor(s). ... and frozen specimens of benign breast disease. A Study to Establish a Registry ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?